Chesnara Plc: Fourth acquisition in two years
12 November 2026
Nuvation Bio Inc. (NUVB) has been attracting attention in the biotech sector, not least because of its significant upside potential of 104.98%, according to analyst ratings...
InMode Ltd. (NASDAQ: INMD), a key player in the medical devices industry, has been capturing attention with its innovative aesthetic medical products. Headquartered in Yokne’am, Israel,..
AMN Healthcare Services Inc (AMN) stands as a key player within the healthcare sector, specifically in the medical care facilities industry. With a market capitalization of..
Oculis Holding AG (OCS), a Switzerland-based clinical-stage biopharmaceutical company, is capturing investor attention with its promising pipeline of ophthalmic treatments and impressive upside potential. Operating within..
Rocket Pharmaceuticals, Inc. (RCKT), a pioneering entity in the biotechnology sector, is capturing attention with its promising pipeline of gene therapies targeting rare and life-threatening diseases...
In the ever-evolving landscape of biotechnology, Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) emerges as a company to watch, particularly for investors seeking opportunities in the healthcare..
Pharvaris N.V. (PHVS) stands out in the biotechnology sector with its promising developments in therapies for rare diseases, particularly those addressing bradykinin-mediated conditions like hereditary angioedema..
Dianthus Therapeutics, Inc. (NASDAQ: DNTH), a burgeoning player in the biotechnology sector, has recently captured the attention of individual investors due to its promising portfolio in..
Neuropace, Inc. (NASDAQ: NPCE) stands out in the healthcare sector, particularly within the competitive medical devices industry, thanks to its innovative solutions for drug-resistant focal epilepsy...
Delcath Systems, Inc. (NASDAQ: DCTH), a pioneering player in the healthcare sector, is gaining attention from investors with its promising potential for substantial upside. Specializing in..
Nutex Health Inc. (NUTX) is carving a prominent niche in the U.S. healthcare sector, focusing on the development and management of micro-hospitals and related healthcare services...
Akso Health Group (NASDAQ: AHG), a key player in the medical distribution sector in China, is capturing the attention of investors with its current challenges and..
Anavex Life Sciences Corp. (NASDAQ: AVXL) stands at the forefront of innovative solutions within the biotechnology sector, drawing substantial attention from investors due to its promising..
Savara, Inc. (NASDAQ: SVRA), a clinical-stage biopharmaceutical company, is capturing investor attention with its focus on rare respiratory diseases and a promising 81% potential upside. Operating..
AbCellera Biologics Inc. (NASDAQ: ABCL) is currently capturing the attention of investors with its significant potential upside, as indicated by a 155.34% increase potential based on..
Fulgent Genetics, Inc. (NASDAQ: FLGT) is making waves in the healthcare sector, particularly within the diagnostics and research industry. With a significant potential upside of 35.97%,..
Vir Biotechnology, Inc. (NASDAQ: VIR) is catching the eye of investors with a staggering potential upside of 116.98%, making it a compelling subject in the biotechnology..
Sionna Therapeutics, Inc. (SION) is a clinical-stage biopharmaceutical company making waves in the healthcare sector, specifically within the biotechnology industry. With its primary focus on developing..
ArriVent BioPharma, Inc. (NASDAQ: AVBP), a dynamic player in the biotechnology industry, is capturing investor attention with a compelling potential upside of 73.29%. This clinical-stage biopharmaceutical..
Intellia Therapeutics, Inc. (NASDAQ: NTLA) stands at the forefront of innovation in the biotechnology sector, focusing on groundbreaking genome editing treatments. As a clinical-stage company, Intellia’s..
